Recombinant CD40 Protein, Canine (His Tag) Recombinant Proteins The canine CD40 (NP_001002982.1) (Glu21-Ala194) was expressed with a polyhistidine tag at the C-terminus The recombinant canine CD40 consists of 184a.a and predicts a molecular weight of 20.4 kDa.
$ $99 In stock
Formulation: The recombinant canine CD40 consists of 184a.a and predicts a molecular weight of 20.4 kDa.
Source: Yeast
Usage: Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use

Recombinant CD40 Protein, Canine (His Tag)

Formulation: Recombinant CD40 Protein was lyophilized from sterile PBS, pH 7.4.1

Source: Yeast

Product Name Recombinant CD40 Protein, Canine (His Tag)
Product Type Recombinant Protein
Source Yeast
Formulation Recombinant CD40 Protein was lyophilized from sterile PBS, pH 7.4.1
Molecular Weight The recombinant canine CD40 consists of 184a.a and predicts a molecular weight of 20.4 kDa.
Purity Greater than 90% as determined by SDS-PAGE
Description The canine CD40 (NP_001002982.1) (Glu21-Ala194) was expressed with a polyhistidine tag at the C-terminus
Host Species Canine
Usage Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use
Storage Store recombinant protein under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
AA Sequence Glu21-Ala194
Product Background CD4, also known as TNFRSF5, is a member of the TNF receptor superfamily which are single transmembrane-spanning glycoproteins. CD4 protein plays an essential role in mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. CD4 protein is expressed in B cells, dendritic cells, macrophages, endothelial cells, and several tumor cell lines. Defects in CD4 result in hyper-IgM immunodeficiency type 3 (HIGM3). In addition, CD4/CD4L interaction is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis.Immune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: ICC AntibodiesImmune Checkpoint Detection: IP AntibodiesImmune Checkpoint Detection: FCM AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint ProteinsImmune Checkpoint TargetsCo-stimulatory Immune Checkpoint Targets ImmunotherapyCancer ImmunotherapyTargeted Therapy
Terminal Glu 21
Bioactivity Please contact us for detailed information